|
Market Closed -
Hong Kong S.E.
03:08:17 2026-11-13 EST
|
5-day change | 1st Jan Change | ||
| 20.24 HKD | -3.71% |
|
+10.24% | +48.28% |
| 11-13 | Zai Lab Limited - Special Call | |
| 11-13 | Zai Lab Says Experimental Drug Reduced Activity of Protein Linked to Atopic Dermatitis by at Least 90% | MT |
Company Valuation: Zai Lab Limited
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 6,059 | 2,946 | 2,688 | 2,853 | 1,962 | 2,766 | - | - |
| Change | - | -51.37% | -8.77% | 6.15% | -31.23% | 40.99% | - | - |
| Enterprise Value (EV) 1 | 4,650 | 1,938 | 1,897 | 2,095 | 1,397 | 2,127 | 2,292 | 2,446 |
| Change | - | -58.33% | -2.13% | 10.47% | -33.34% | 52.33% | 7.75% | 6.72% |
| P/E | -8.29x | -6.63x | -7.9x | -10.1x | -11x | -13.2x | -11.5x | -21x |
| PBR | 4.35x | - | 3.34x | 3.36x | 2.73x | 3.81x | 6.62x | 6.24x |
| PEG | - | 0.2x | 0.3x | 0.4x | 0.3x | -0.8x | -0.8x | 0.5x |
| Capitalization / Revenue | 42x | 13.7x | 10.1x | 7.15x | 4.26x | 6.3x | 5.15x | 3.89x |
| EV / Revenue | 32.2x | 9.01x | 7.11x | 5.25x | 3.04x | 4.84x | 4.26x | 3.44x |
| EV / EBITDA | -6.7x | -4.89x | -5.3x | -7.75x | -6.51x | -7.95x | -9.67x | -14.3x |
| EV / EBIT | -6.64x | -4.79x | -5.17x | -7.43x | -6.09x | -7.63x | -9.94x | -13.8x |
| EV / FCF | -8.19x | -4.94x | -9.23x | -9.5x | -8.5x | -12.1x | -13.2x | -21.2x |
| FCF Yield | -12.2% | -20.2% | -10.8% | -10.5% | -11.8% | -8.25% | -7.57% | -4.71% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -7.58 | -4.63 | -3.46 | -2.6 | -1.6 | -1.869 | -2.13 | -1.174 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 144.3 | 215 | 266.7 | 399 | 460.2 | 439.1 | 537.5 | 711 |
| EBITDA 1 | -693.6 | -396.1 | -357.5 | -270.3 | -214.4 | -267.8 | -236.9 | -171.5 |
| EBIT 1 | -700.1 | -404.4 | -366.6 | -282.1 | -229.4 | -278.8 | -230.6 | -177 |
| Net income 1 | -704.5 | -443.3 | -334.6 | -257.1 | -175.5 | -213.5 | -218.2 | -140.1 |
| Net Debt 1 | -1,409 | -1,008 | -791.3 | -757.9 | -565.3 | -638.7 | -473.9 | -319.7 |
| Reference price 2 | 62.85 | 30.70 | 27.33 | 26.19 | 17.64 | 24.60 | 24.60 | 24.60 |
| Nbr of stocks (in thousands) | 96,409 | 95,972 | 98,349 | 108,937 | 111,219 | 112,445 | - | - |
| Announcement Date | 3/1/22 | 3/1/23 | 2/27/24 | 2/27/25 | 2/26/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 42.25x | 14.3x | 30.31x | 0.47% | 1,286B | |
| 41.82x | 7.01x | 19.73x | 1.87% | 688B | |
| 37.62x | 8.63x | 17.81x | 2.34% | 521B | |
| 21.75x | 5.27x | 13.2x | 2.48% | 386B | |
| 104.88x | 5.98x | 25.49x | 2.3% | 364B | |
| 24x | 5.82x | 14.17x | 2.73% | 302B | |
| 24.25x | 4.85x | 13.63x | 1.8% | 287B | |
| 24.04x | 7.38x | 13.56x | 2.17% | 252B | |
| -39.49x | 7.32x | 46.07x | 1.96% | 208B | |
| Average | 31.24x | 7.40x | 21.55x | 2.01% | 477B | |
| Weighted average by Cap. | 37.57x | 8.95x | 22.68x | 1.68% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ZLAB Stock
- 9688 Stock
- Valuation Zai Lab Limited
Select your edition
All financial news and data tailored to specific country editions
